Bit Capital Gmb H Keros Therapeutics, Inc. Transaction History

Bit Capital Gmb H

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$15.64 - $70.0 $410,346 - $1.84 Million	-26,237 Closed	0 $0
Q3 2024 Feb 12, 2025	BUY	$41.68 - $58.07 $145,838 - $203,186	3,499 Added 15.39%	26,237 $1.52 Billion
Q2 2024 Feb 12, 2025	BUY	$44.58 - $66.89 $481,241 - $722,077	10,795 Added 90.39%	22,738 $1.04 Billion
Q1 2024 Feb 12, 2025	BUY	$41.26 - $70.48 $62,385 - $106,565	1,512 Added 14.5%	11,943 $791 Million
Q4 2023 Feb 12, 2025	BUY	$27.12 - $41.05 $94,079 - $142,402	3,469 Added 49.83%	10,431 $415 Million
Q2 2023 Feb 12, 2025	BUY	$37.26 - $51.01 $259,404 - $355,131	6,962 New	6,962 $280 Million
Q1 2023 Feb 12, 2025	SELL	$41.44 - $59.32 $55,115 - $78,895	-1,330 Closed	0 $0
Q4 2022 Feb 12, 2025	SELL	$39.45 - $51.77 $14,596 - $19,154	-370 Reduced 21.76%	1,330 $63.9 Million
Q1 2022 Feb 12, 2025	BUY	$42.12 - $59.36 $71,604 - $100,912	1,700 New	1,700 $92.4 Million

172

30.7M

62.4K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $261M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.